Please use this identifier to cite or link to this item:
https://doi.org/10.3390/biomedicines11020508
DC Field | Value | |
---|---|---|
dc.title | Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC | |
dc.contributor.author | Goh, Kah Yee | |
dc.contributor.author | Cheng, Terence You De | |
dc.contributor.author | Tham, Su Chin | |
dc.contributor.author | Lim, Darren Wan-Teck | |
dc.date.accessioned | 2024-06-14T05:03:34Z | |
dc.date.available | 2024-06-14T05:03:34Z | |
dc.date.issued | 2023-02 | |
dc.identifier.citation | Goh, Kah Yee, Cheng, Terence You De, Tham, Su Chin, Lim, Darren Wan-Teck (2023-02). Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC. BIOMEDICINES 11 (2). ScholarBank@NUS Repository. https://doi.org/10.3390/biomedicines11020508 | |
dc.identifier.issn | 2227-9059 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/248896 | |
dc.description.abstract | Non-small cell lung cancer (NSCLC) constitutes the majority of the lung cancer population and the prognosis is poor. In recent years, immunotherapy has become the standard of care for advanced NSCLC patients as numerous trials demonstrated that immune checkpoint inhibitors (ICI) are more efficacious than conventional chemotherapy. However, only a minority of NSCLC patients benefit from this treatment. Therefore, there is an unmet need for biomarkers that could accurately predict response to immunotherapy. Liquid biopsy allows repeated sampling of blood-based biomarkers in a non-invasive manner for the dynamic monitoring of treatment response. In this review, we summarize the efforts and progress made in the identification of circulating biomarkers that predict immunotherapy benefit for NSCLC patients. We also discuss the challenges with future implementation of circulating biomarkers into clinical practice. | |
dc.language.iso | en | |
dc.publisher | MDPI | |
dc.source | Elements | |
dc.subject | Science & Technology | |
dc.subject | Life Sciences & Biomedicine | |
dc.subject | Biochemistry & Molecular Biology | |
dc.subject | Medicine, Research & Experimental | |
dc.subject | Pharmacology & Pharmacy | |
dc.subject | Research & Experimental Medicine | |
dc.subject | liquid biopsy | |
dc.subject | biomarkers | |
dc.subject | immunotherapy | |
dc.subject | checkpoint inhibition | |
dc.subject | lung cancer | |
dc.subject | CELL LUNG-CANCER | |
dc.subject | IMMUNE CHECKPOINT INHIBITOR | |
dc.subject | OPEN-LABEL | |
dc.subject | PERIPHERAL-BLOOD | |
dc.subject | TUMOR-CELLS | |
dc.subject | PD-1/PD-L1 PATHWAY | |
dc.subject | LYMPHOCYTE RATIO | |
dc.subject | LIQUID BIOPSY | |
dc.subject | T-CELLS | |
dc.subject | DOCETAXEL | |
dc.type | Review | |
dc.date.updated | 2024-06-12T13:47:23Z | |
dc.contributor.department | BIOCHEMISTRY | |
dc.contributor.department | DUKE-NUS MEDICAL SCHOOL | |
dc.description.doi | 10.3390/biomedicines11020508 | |
dc.description.sourcetitle | BIOMEDICINES | |
dc.description.volume | 11 | |
dc.description.issue | 2 | |
dc.published.state | Published | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Circulating Biomarkers for Prediction of Immunotherapy Response in NSCLC.pdf | 720.76 kB | Adobe PDF | OPEN | None | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.